Therapeutic immunosuppressive agents, surgical removal are two popular liver fibrosis treatments available today

 Liver Fibrosis (also known as fatty liver disease) is a disease that can be either chronic or acute. Acute liver disease happens suddenly, usually due to some type of trauma. Chronic liver disease, on the other hand, occurs over time, sometimes due to a reaction to certain medications or a mild genetic enzyme deficiency. The two types of the disease are separated by a difference in symptoms, severity, and the treatment of the disease.

https://www.coherentmarketinsights.com/market-insight/liver-fibrosis-treatment-market-2320


There is also some experimental liver fibrosis treatment available. For example, the Ayurvedic combination of Gastrodiazza (Moringa pteridosperms), Kutki (Picrorrhiza kurroa), Shatavari (Asparagus racemosus), Abhrak Bhasma, Suvarna Bhasma, Yashtimadhuk (Glycyrrhiza glabra), Chandan (Santalum album), Manjishtha (Rubia cordifolia), Saraiva (Hemidesmus indicus), Haridra (Curcuma longa), Amalaki (Emblica Officinalis), Patol (Tricosanthe dioica), Patha (Cissampelos pareira), Musta (Cyperus rotundus) and Nimba (Azadirachta indica). 

Another advanced liver fibrosis treatment is a combination of biological therapy with micro-nutrients and medical procedures. Clinical studies suggest that these treatments improve clinical outcomes, but there is no proof in this regard. This combination includes chemotherapy with carboplatin, bromocriptine, methotrexate, cisplatin, vincristine, vinblastine, gemcitabine, intravenous immunoglobulin, vitamin K, methotrexate, or combination treatment. Another advanced liver injury and treatment is called extracorporeal shock wave therapy (ESWT), a combination of pharmacological and non-pharmacological approaches. This approach combines ESWL, which is an ultrafast laser treatment, with pharmacological agents such as doxorubicin, trifluoperazine, and chlorhexidine. These drugs interfere with protein synthesis, induce asthmatic-like responses, and reduce protein accumulation within the blood vessels. The combination of these two drugs reduces the amount of protein produced by the liver and thus prevents or delays the progression of liver fibrosis. Micro-nutrients support the cellular repair process, stimulate cell proliferation, and increase the expression of important molecules like superoxide dismutase (SOD), an antioxidant enzyme superoxide dismutase (OR Rebel), and glutathione, that may be affected by oxidative stress. Cytokines released by inflammatory cells bind the SOD and OR Rebel to stop their activities and prevent their accumulation... Read more

Post a Comment

Previous Post Next Post